Trial Profile
A multicentre study of direct antiviral agent treatment schedule in patients with hepatitis C virus genotype 3 infection in a real life setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 10 Jul 2017 New trial record